alanine has been researched along with Abnormality, Heart in 7 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"Cyanosis was not associated with any other amino acid levels." | 1.33 | Free amino acids in hearts of pediatric patients with congenital heart disease: the effects of cyanosis, age, and pathology. ( Angelini, GD; Caputo, M; Modi, P; Parry, AJ; Pawade, A; Reeves, BC; Suleiman, MS, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Trimouille, A | 1 |
Tingaud-Sequeira, A | 1 |
Lacombe, D | 1 |
Duelund Hjortshøj, T | 1 |
Kreiborg, S | 1 |
Buciek Hove, H | 1 |
Rooryck, C | 1 |
Sendzikaite, S | 1 |
Heying, R | 1 |
Milanesi, O | 1 |
Hanseus, K | 1 |
Michel-Behnke, I | 1 |
Modi, P | 1 |
Suleiman, MS | 1 |
Reeves, BC | 1 |
Pawade, A | 1 |
Parry, AJ | 1 |
Angelini, GD | 1 |
Caputo, M | 1 |
Lundell, KH | 1 |
Sabel, KG | 1 |
Eriksson, BO | 1 |
Haymond, MW | 1 |
Strauss, AW | 1 |
Arnold, KJ | 1 |
Bier, DM | 1 |
Chesney, RW | 1 |
Kaplan, BS | 1 |
Freedom, RM | 1 |
Haller, JA | 1 |
Drummond, KN | 1 |
Anand, KJ | 1 |
Hansen, DD | 1 |
Hickey, PR | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Stress Response in Children Undergoing Cardiac Surgery: a Prospective Randomized Comparison Between Low Dose Fentanyl (LDF), Low Dose Fentanyl Plus Dexmedetomidine (LDF + Dex) and High Dose Fentanyl (HDF).[NCT00848393] | Phase 2 | 52 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT00848393)
Timeframe: Hospital admission to discharge from CTICU (average of 2-4 days)
Intervention | Days (Median) |
---|---|
Fentanyl (High Dose) | 1 |
Fentanyl (Low Dose) | 1 |
Fentanyl (Low Dose) + Dexmedetomidine | 2 |
(NCT00848393)
Timeframe: Time of intubation to extubation (variable)
Intervention | Hours (Median) |
---|---|
Fentanyl (High Dose) | 10.75 |
Fentanyl (Low Dose) | 3.79 |
Fentanyl (Low Dose) + Dexmedetomidine | 2.4 |
The ABAS-II is designed to evaluate whether an individual displays various functional skills necessary for daily living without the assistance of others. Thus, this instrument focuses on independent behaviors and measures what an individual actually does, in addition to measuring what he or she may be able to do. In addition, the ABAS-II focuses on behaviors an individual displays on his or her own, without assistance from others. The Parent/Primary Caregiver Form is a comprehensive, diagnostic measure of the adaptive skills that have primary relevance for the functioning of infants, toddlers, and preschoolers in the home and other settings, and can be completed by parents or other primary care providers. Each composite or domain score is determined by summing the appropriate scaled scores and then determining its equivalent composite or domain score by looking it up in a table located in the manual.The range for all scores is 50-150, with a higher score equaling a better outcome. (NCT00848393)
Timeframe: 1-4 yrs post-surgery
Intervention | units on a scale (Mean) | |||
---|---|---|---|---|
ABAS-II General Adaptive Composite Score | ABAS-II Conceptual Adaptive Domain Score | ABAS-II Social Adaptive Domain Score | ABAS-II Practical Adaptive Domain Score | |
Fentanyl (High Dose) | 96 | 99 | 102 | 93 |
Fentanyl (Low Dose) | 102 | 106 | 106 | 96 |
Fentanyl (Low Dose) + Dexmedetomidine | 100 | 99 | 105 | 95 |
N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-α. (NCT00848393)
Timeframe: Blood draws to measure cytokines levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.
Intervention | pg/mL (Mean) | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline ACTH (pg/mL) | Post-Sternotomy ACTH (pg/mL) | Post-Bypass ACTH (pg/mL) | End-Of-Surgery ACTH (pg/mL) | 24 hour Post-Surgery ACTH (pg/mL) | Baseline TNF-alpha (pg/mL) | Post-Sternotomy TNF-alpha (pg/mL) | Post-Bypass TNF-alpha (pg/mL) | End-Of-Surgery TNF-alpha (pg/mL) | 24 hour Post-Surgery TNF-alpha (pg/mL) | Baseline IL-6 (pg/mL) | Post-Sternotomy IL-6 (pg/mL) | Post-Bypass IL-6 (pg/mL) | End-Of-Surgery IL-6 (pg/mL) | 24 hour Post-Surgery IL-6 (pg/mL) | Baseline IL-8 (pg/mL) | Post-Sternotomy IL-8 (pg/mL) | Post-Bypass IL-8 (pg/mL) | End-Of-Surgery IL-8 (pg/mL) | 24 hour Post-Surgery IL-8 (pg/mL) | Baseline IL-10 (pg/mL) | Post-Sternotomy IL-10 (pg/mL) | Post-Bypass IL-10 (pg/mL) | End-Of-Surgery IL-10 (pg/mL) | 24 hour Post-Surgery IL-10 (pg/mL) | |
Fentanyl (High Dose) | 116.9 | 44.5 | 57.2 | 66.4 | 12.7 | 15.70077 | 26.51846 | 24.30615 | 23.87077 | 15.79 | 6.637058824 | 5.402353 | 5.098824 | 20.48571 | 126.0813 | 17.12353 | 20.77647 | 9.770588 | 28.1 | 49.07143 | 10.82353 | 9.911765 | 9.488235 | 345.4412 | 10.80667 |
Fentanyl (Low Dose) | 182.7 | 86.2 | 172.7 | 155.0 | 53.2 | 25.294 | 24.497 | 25.787 | 24.857 | 11.954 | 4.757142857 | 12.17333 | 5.509375 | 22.47333 | 117.975 | 10.44286 | 10.66667 | 10.13125 | 33.12667 | 47.25 | 9.9 | 9.9 | 9.9 | 325.55 | 14.80833 |
Fentanyl (Low Dose) + Dexmedetomidine | 135.3 | 106.9 | 191.6 | 154.1 | 22.4 | 8.018182 | 17.88636 | 20.34364 | 23.06091 | 21.13909 | 5.542857143 | 6.241333 | 5.040667 | 20.79231 | 142.1571 | 10.25714 | 10.86667 | 9.673333 | 37.22143 | 24.27143 | 12.76429 | 14.10667 | 12.30667 | 569.2714 | 9.692857 |
The Stanford-Binet Intelligence Scale is now in its fifth edition (SB5) and was released in 2003. It is a cognitive ability and intelligence test that is used to diagnose developmental or intellectual deficiencies in young children. The test measures five weighted factors and consists of both verbal and nonverbal subtests. The five factors being tested are knowledge, quantitative reasoning, visual-spatial processing, working memory, and fluid reasoning. Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). Higher scores suggest a higher level of functioning related to each category. (NCT00848393)
Timeframe: 1-4 yrs post-surgery
Intervention | units on a scale (Mean) | ||||
---|---|---|---|---|---|
Quantative Reasoning Score | Knowledge Score | Visual Spatial Processing Score | Working Memory Score | Fluid Reasoning Score | |
Fentanyl (High Dose) | 106 | 91 | 91 | 94 | 86 |
Fentanyl (Low Dose) | 96 | 97 | 97 | 92 | 93 |
Fentanyl (Low Dose) + Dexmedetomidine | 82 | 95 | 92 | 84 | 75 |
The Stanford-Binet test evaluates the overall IQ score from the assessment of cognitive ability. The test consists of 15 subtests, grouped into the four area scores. Six subtests are administered to all age levels. The subtests are: Vocabulary, Comprehension, Pattern Analysis, Quantitative, Bead Memory, and Memory for Sentences. Number of tests administered and test difficulty are based on the test taker's age and performance on subtest measuring word knowledge. The word knowledge subtest is given to all test takers and is the first subtest administered. A score of 100 is in the normal or average range. Higher scores suggest a higher level of functioning related to each category. (University of Cincinnati, 2003) Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). (NCT00848393)
Timeframe: 1-4 yrs. post-surgery
Intervention | IQ (Mean) | ||
---|---|---|---|
Nonverbal IQ composite score | Verbal IQ composite score | Full-scale IQ composite score | |
Fentanyl (High Dose) | 92 | 93 | 93 |
Fentanyl (Low Dose) | 98 | 91 | 94 |
Fentanyl (Low Dose) + Dexmedetomidine | 89 | 80 | 83 |
Cortisol, epinephrine, and norepinephrine assayed by enzyme-linked immunosorbent assay (ELISA). (NCT00848393)
Timeframe: Blood draws to measure stress hormone levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.
Intervention | ng/mL (Mean) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline Norepinephrine | Post-Sternotomy Norepinephrine | Post-Bypass Norepinephrine | End-of-Surgery Norepinephrine | 24 hour Post-Surgery Norepinephrine | Baseline ephinephrine | Post-Sternotomy Epinephrine | Post-Bypass Epinephrine | End-of-Surgery Epinephrine | 24 hour Post-Surgery Epinephrine | Baseline Cortisol | Post-Sternotomy Cortisol | Post-Bypass Cortisol | End-of-Surgery Cortisol | 24 hour Post-Surgery Cortisol | |
Fentanyl (High Dose) | 13.32618 | 16.2606 | 23.35796 | 11.22376 | 19.03031 | 2.7848 | 2.376012 | 18.176 | 14.65742 | 5.004787 | 334.7762 | 353.5396 | 279.0063 | 333.0644 | 237.5506 |
Fentanyl (Low Dose) | 19.34153 | 17.08766 | 22.31064 | 10.74731 | 20.85433 | 6.439221 | 9.843591 | 21.9075 | 8.620669 | 3.537063 | 449.1974 | 363.5948 | 395.1298 | 463.3857 | 266.8754 |
Fentanyl (Low Dose) + Dexmedetomidine | 19.45968 | 12.74458 | 19.73612 | 7.727055 | 26.67379 | 5.876335 | 10.89824 | 20.5294 | 8.083004 | 4.418208 | 352.4913 | 361.0074 | 354.8089 | 387.3673 | 265.7373 |
7 other studies available for alanine and Abnormality, Heart
Article | Year |
---|---|
Description of a family with X-linked oculo-auriculo-vertebral spectrum associated with polyalanine tract expansion in ZIC3.
Topics: Adolescent; Adult; Alanine; Anal Canal; Branchial Region; Child; Child, Preschool; DNA Copy Number V | 2020 |
COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper.
Topics: Adenosine Monophosphate; Alanine; Anti-Arrhythmia Agents; Anticoagulants; Antiviral Agents; Arrhythm | 2021 |
Free amino acids in hearts of pediatric patients with congenital heart disease: the effects of cyanosis, age, and pathology.
Topics: Aging; Alanine; Amino Acids; Biopsy; Child; Child, Preschool; Cyanosis; Glutamic Acid; Heart Defects | 2006 |
Plasma metabolites after a lipid load in infants with congenital heart disease.
Topics: Alanine; Blood Glucose; Chromatography, Gas; Chromatography, Thin Layer; Fat Emulsions, Intravenous; | 1999 |
Glucose homeostasis in children with severe cyanotic congenital heart disease.
Topics: Alanine; Blood Glucose; Child, Preschool; Fasting; Glucagon; Glucose; Heart Defects, Congenital; Hom | 1979 |
Acute renal failure: an important complication of cardiac surgery in infants.
Topics: Acute Kidney Injury; Alanine; Cardiac Surgical Procedures; Female; Heart Defects, Congenital; Humans | 1975 |
Hormonal-metabolic stress responses in neonates undergoing cardiac surgery.
Topics: Alanine; Aldosterone; beta-Endorphin; Blood Glucose; Cardiac Surgical Procedures; Epinephrine; Femal | 1990 |